These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26876697)

  • 1. The Frequency of Signs of Meibomian Gland Dysfunction in Children with Epidermolysis Bullosa.
    Jones SM; Smith KA; Jain M; Mellerio JE; Martinez A; Nischal KK
    Ophthalmology; 2016 May; 123(5):991-9. PubMed ID: 26876697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eye in epidermolysis bullosa.
    Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D
    Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed diagnostic criteria for obstructive meibomian gland dysfunction.
    Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Fukuoka S; Tomidokoro A; Amano S
    Ophthalmology; 2009 Nov; 116(11):2058-63.e1. PubMed ID: 19744718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain.
    Viso E; Rodríguez-Ares MT; Abelenda D; Oubiña B; Gude F
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2601-6. PubMed ID: 22427596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meibomian Gland Dysfunction in a Youthful Clinical Sample in Ghana.
    Asiedu K; Kyei S; Dzasimatu SK; Morny EKA
    Optom Vis Sci; 2018 Apr; 95(4):349-353. PubMed ID: 29561504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dental caries risk in hereditary epidermolysis bullosa.
    Wright JT; Fine JD; Johnson L
    Pediatr Dent; 1994; 16(6):427-32. PubMed ID: 7854950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of epidermolysis bullosa in Scotland.
    Horn HM; Priestley GC; Eady RA; Tidman MJ
    Br J Dermatol; 1997 Apr; 136(4):560-4. PubMed ID: 9155958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Definitive and Reliable Grading Scales for Meibomian Gland Dysfunction.
    Arita R; Minoura I; Morishige N; Shirakawa R; Fukuoka S; Asai K; Goto T; Imanaka T; Nakamura M
    Am J Ophthalmol; 2016 Sep; 169():125-137. PubMed ID: 27345733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications.
    Uzunosmanoglu E; Mocan MC; Kocabeyoglu S; Karakaya J; Irkec M
    Cornea; 2016 Aug; 35(8):1112-6. PubMed ID: 27055218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
    Intong LR; Murrell DF
    Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C
    Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic abnormalities and clinical classification of epidermolysis bullosa.
    Mitsuhashi Y; Hashimoto I
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S29-33. PubMed ID: 12677430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa.
    Kho YC; Rhodes LM; Robertson SJ; Su J; Varigos G; Robertson I; Hogan P; Orchard D; Murrell DF
    Arch Dermatol; 2010 Jun; 146(6):635-40. PubMed ID: 20566927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinic-Based Study on Meibomian Gland Dysfunction in Japan.
    Amano S; Inoue K
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1283-1287. PubMed ID: 28241316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause-specific risks of childhood death in inherited epidermolysis bullosa.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    J Pediatr; 2008 Feb; 152(2):276-80. PubMed ID: 18206702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meibomian gland dysfunction and tear cytokines after cataract surgery according to preoperative meibomian gland status.
    Jung JW; Han SJ; Nam SM; Kim TI; Kim EK; Seo KY
    Clin Exp Ophthalmol; 2016 Sep; 44(7):555-562. PubMed ID: 26989003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    Laryngoscope; 2007 Sep; 117(9):1652-60. PubMed ID: 17762793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.